Kernal Biologics
PrivateLast Round
Grant
Oct 7, 2025
Total Funding Raised
$25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kernal Biologics is a biotechnology company that develops mRNA-based immunotherapies for cancer and autoimmune diseases using AI-designed, cell-selective mRNA and targeted lipid nanoparticle technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kernal Biologics Comparables
Compare Kernal Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RNAimmune | 82% | |
| Strand Therapeutics | 81% | |
| Myeloid Therapeutics | 80% | |
Kernal Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2025 | ||||
| Series A | Jul 7, 2022 |
Kernal Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HBM Healthcare Investments | Series A |
| Amgen Ventures | Series A |
| ARPA-H | Grant |
| Civilization Ventures | Series A |
| Hummingbird Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Grew 19% QoQ, from 16 to 19 employees.
- Oct 8, 2025
KR-402 is in development for B cell cancers.
Kernal Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kernal Biologics's valuation, stock price, and market status.